NanoEntek, Inc. (KOSDAQ:039860)
South Korea
· Delayed Price · Currency is KRW 6,240.00
-390.00 (-5.88%)
At close: Mar 9, 2026
NanoEntek Revenue
NanoEntek had revenue of 8.55B KRW in the quarter ending September 30, 2025, with 8.07% growth. This brings the company's revenue in the last twelve months to 34.74B, up 18.53% year-over-year. In the year 2024, NanoEntek had annual revenue of 30.46B with 13.52% growth.
Revenue (ttm)
34.74B
Revenue Growth
+18.53%
P/S Ratio
6.84
Revenue / Employee
358.11M
Employees
97
Market Cap
237.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 30.46B | 3.63B | 13.52% |
| Dec 31, 2023 | 26.84B | -8.36B | -23.76% |
| Dec 31, 2022 | 35.20B | -583.53M | -1.63% |
| Dec 31, 2021 | 35.78B | 6.34B | 21.54% |
| Dec 31, 2020 | 29.44B | 3.19B | 12.14% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bumhan Fuel Cell | 37.19B |
| JEIO Co., Ltd. | 65.05B |
| CYMECHS | 180.27B |
| YUNSUNG F&C Co.,Ltd | 151.78B |
| OE Solutions | 52.13B |
| DAE HWA Pharmaceutical | 149.47B |
| Genohco. | 56.31B |
| Ycchem | 77.14B |